Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jounce Therapeutics (JNCE)
NASDAQ:JNCE
Jounce Therapeutics (JNCE) Financial Statements
0 Followers
Jounce Therapeutics Financial Overview
| Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 82.00M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 82.00M | - | - | - | - |
| EBIT | $ 51.08M | $ -31.41M | $ -33.71M | $ -37.46M | $ -30.28M |
| EBITDA | $ 51.67M | $ -30.91M | $ -33.15M | $ -36.87M | $ -29.64M |
| Net Income Common Stockholders | $ 50.96M | $ -31.00M | $ -33.51M | $ -37.37M | $ -30.23M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 189.54M | $ 128.61M | $ 148.56M | $ 155.42M | $ 178.57M |
| Total Assets | $ 212.55M | $ 158.08M | $ 188.90M | $ 214.67M | $ 252.70M |
| Total Debt | $ 10.02M | $ 10.95M | $ 11.89M | $ 12.81M | $ 13.69M |
| Net Debt | $ -179.52M | $ -117.66M | $ -136.68M | $ -142.61M | $ -164.88M |
| Total Liabilities | $ 29.44M | $ 28.72M | $ 31.17M | $ 25.71M | $ 28.89M |
| Stockholders Equity | $ 183.11M | $ 129.36M | $ 157.73M | $ 188.96M | $ 223.81M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 59.01M | $ -31.78M | $ -23.75M | $ -33.27M | $ -28.33M |
| Operating Cash Flow | $ 59.23M | $ -31.54M | $ -23.41M | $ -33.17M | $ -28.20M |
| Investing Cash Flow | $ 14.23M | $ 30.91M | $ 40.70M | $ -2.36M | $ -21.68M |
| Financing Cash Flow | - | $ 0.00 | $ 33.00K | $ 409.00K | $ 49.00K |
Jounce Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.